Hip arthrosis and surgical intervention: what and when?

Clin Cases Miner Bone Metab. 2013 Jan;10(1):41-6. doi: 10.11138/ccmbm/2013.10.1.041.

Innocenti M, Nistri L, Biondi M, Del Prete A, Giorgini M, Macera A, Soderi S.

Source

Orthopaedic Clinic, Department of Special Surgical Science, University of Florence, CTO, Florence, Italy.

Abstract

Osteoarthritis of the hip is a common pathology and involves forms of disability and need for treatments that affect the quality of life of patients and their families, and in general of the whole society. It should be considered as such degenerative joint disease is increasing as the increase in life expectancy and musculoskeletal trauma, the latter responsible for secondary forms of osteoarthritis. The treatment of osteoarthritis of the hip has changed a lot over the years, since the earlier diagnosis and, before, with prevention through proper lifestyle.

Growth factors in the treatment of early osteoarthritis.

 Clin Cases Miner Bone Metab. 2013 Jan;10(1):26-9. doi: 10.11138/ccmbm/2013.10.1.026.

Civinini R, Nistri L, Martini C, Redl B, Ristori G, Innocenti M.

Source

Orthopedic Clinic, Department of Special Surgical Science, University of Florence, CTO, Florence, Italy.

Abstract

Regenerative medicine is the science that studies the regeneration of biological tissues obtained through use of cells, with the aid of support structures and with biomolecules such as growth factors. As regards the growth factors the PRP, or the platelet-rich plasma, obtained from a withdrawal of autologous blood, concentrating the platelets, represents a safe, economical, easy to prepare and easy to apply source of growth factors.

Matt Kemp gets PRP injection

Los Angeles Dodgers outfielder Matt Kemp received an injection of platelet-rich plasma in his sore AC joint, according to a Los Angeles Times report.
Kemp had an MRI exam on his left shoulder Tuesday that confirmed the irritation in his AC joint, according to manager Don Mattingly.

A biological therapy to osteoarthritis treatment using platelet-rich plasma.

Expert Opin Biol Ther. 2013 Aug;13(8):1161-72. doi: 10.1517/14712598.2013.801450. Epub 2013 Jun 12.

Anitua E, Sánchez M, Orive G, Padilla S.

Source

Foundation Eduardo Anitua Biotechnology Institute , Jacinto Quincoces, 39, 01007 Vitoria (Álava) , Spain +34 945 160 653 ; eduardoanitua.@eduardoanitua.com; gorka.orive@bti-implant.es, gorka.orive@ehu.es.

Abstract

Introduction: Osteoarthritis (OA) is a degenerative disease affecting the synovial joint. It is caused by cells exposure to non-physiological stimuli, either mechanical or biochemical, and the loss of bone-cartilage homeostasis. Some of these changes, however, may be reversed by the use of single or combined growth factors, suggesting that the treatment of OA could be addressed using a pool of growth factors.

Treatment of knee chondropathy with platelet rich plasma. Preliminary results at 6 months of follow-up with only one injection.

Torrero JI, Aroles F, Ferrer D.

Source

Orthopaedic and Trauma Unit, Nostra Senyora de Meritxell Hospital, Principality of Andorra. jtorrero@saas.ad

Abstract

Application of new biological treatments in orthopaedics is controversial nowadays. Surgeons and practitioners know how difficult can be to choose a solution for chondral injuries. Joint damages are from little contusions, osteochondral fractures, avascular necrosis, osteochondritis and degenerative processes like osteoarthritis and rheumatisms. All mentioned have a common problem: the lack of regenerating hyaline cartilage by themselves. Recently, PRP have been used to treat early moderate chondropathies.

Rehabilitation of a partially torn distal triceps tendon after platelet rich plasma injection: a case report.

Cheatham SW, Kolber MJ, Salamh PA, Hanney WJ.

Source

California State University Dominguez Hills, Carson, CA, USA.

Abstract

BACKGROUND:

Platelet Rich Plasma (PRP) is an emerging non-surgical intervention used for the treatment of tendon and ligament pathology. Despite the growing popularity of PRP in musculoskeletal medicine, there is a paucity of research that describes appropriate rehabilitation procedures following this intervention.

Customizing PRP “Ingenious”

Elizabeth Hofheinz, M.P.H., M.Ed. • Thu, June 20th, 2013
A June 5, 2013 scientific article by Satoshi Terada, M.D., et al. recently appeared in the Journal of Bone and Joint Surgery (JBJS). The study, “Use of an Antifibrotic Agent Improves the Effect of Platelet-Rich Plasma [PRP] on Muscle Healing After Injury,” was sufficiently interesting to provoke an invited commentary. Christopher H. Evans, Ph.D., D.Sc. of Beth Israel Deaconess Medical Center, Boston, Massachusetts, was a referee on the paper and was asked by those at JBJS to give his thoughts.